Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Beaver

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Plant Disease|January 29, 2019
Isolates of Rhizoctonia solani Can Produce both Web Blight and Root Rot Symptoms in Common Bean (Phaseolus vulgaris L.)Suheidy Valentín Torres, María M Vargas, Graciela Godoy-Lutz, et al.
Virology|October 1, 1994
Whitefly transmission and efficient ssDNA accumulation of bean golden mosaic geminivirus require functional coat proteinO Azzam, J Frazer, D de la Rosa, et al.
Journal of Clinical Pharmacology|January 11, 2014
Population pharmacokinetics of TC-5214, a nicotinic channel modulator, in phase I and II clinical studiesHongmei Xu, Anja Henningsson, Sofie Alverlind, et al.
The American Journal of Gastroenterology|January 1, 1991
The combination of prednisone and colchicine in patients with primary sclerosing cholangitisK D Lindor, R H Wiesner, L J Colwell, et al.
Transplantation Proceedings|February 1, 1991
Bone disease in liver transplant recipients: incidence, timing, and risk factorsM K Porayko, R H Wiesner, J E Hay, et al.
Vision Research|May 23, 2001
Continued neurogenesis is not a pre-requisite for regeneration of a topographic retino-tectal projectionR S Beaver, S A Dunlop, A M Harman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophreniaJeffrey A Lieberman, Geoffrey Dunbar, Anthony C Segreti, et al.
CNS Neuroscience & Therapeutics|December 2, 2008
TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activityPatrick M Lippiello, Jessica S Beaver, Gregory J Gatto, et al.
The Plant Genome|June 19, 2023
Genetic variation in a tepary bean (Phaseolus acutifolius A. Gray) diversity panel reveals loci associated with biotic stress resistanceNolan Bornowski, John P Hart, Ana Vargas Palacios, et al.
Critical Care Medicine|April 12, 2006
Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trialJean-Louis Vincent, Herbert D M H Spapen, Jacques Creteur, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Plant Disease|January 29, 2019
Isolates of Rhizoctonia solani Can Produce both Web Blight and Root Rot Symptoms in Common Bean (Phaseolus vulgaris L.)Suheidy Valentín Torres, María M Vargas, Graciela Godoy-Lutz, et al.
Virology|October 1, 1994
Whitefly transmission and efficient ssDNA accumulation of bean golden mosaic geminivirus require functional coat proteinO Azzam, J Frazer, D de la Rosa, et al.
Journal of Clinical Pharmacology|January 11, 2014
Population pharmacokinetics of TC-5214, a nicotinic channel modulator, in phase I and II clinical studiesHongmei Xu, Anja Henningsson, Sofie Alverlind, et al.
The American Journal of Gastroenterology|January 1, 1991
The combination of prednisone and colchicine in patients with primary sclerosing cholangitisK D Lindor, R H Wiesner, L J Colwell, et al.
Transplantation Proceedings|February 1, 1991
Bone disease in liver transplant recipients: incidence, timing, and risk factorsM K Porayko, R H Wiesner, J E Hay, et al.
Vision Research|May 23, 2001
Continued neurogenesis is not a pre-requisite for regeneration of a topographic retino-tectal projectionR S Beaver, S A Dunlop, A M Harman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophreniaJeffrey A Lieberman, Geoffrey Dunbar, Anthony C Segreti, et al.
CNS Neuroscience & Therapeutics|December 2, 2008
TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activityPatrick M Lippiello, Jessica S Beaver, Gregory J Gatto, et al.
The Plant Genome|June 19, 2023
Genetic variation in a tepary bean (Phaseolus acutifolius A. Gray) diversity panel reveals loci associated with biotic stress resistanceNolan Bornowski, John P Hart, Ana Vargas Palacios, et al.
Critical Care Medicine|April 12, 2006
Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trialJean-Louis Vincent, Herbert D M H Spapen, Jacques Creteur, et al.
Pageof 3